Venus Remedies Limited (BOM:526953)
India · Delayed Price · Currency is INR 1,780.10
-6.70 (-0.37%)
At close: Aug 17, 2026
Venus Remedies Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 23,884 | 11,036 | 4,005 | 4,363 | 2,165 | 3,594 | |
Market Cap Growth | 270.97% | 175.57% | -8.21% | 101.54% | -39.76% | 6.04% |
Enterprise Value | 22,974 | 8,822 | 3,072 | 4,073 | 1,938 | 3,609 |
Last Close Price | 1786.80 | 820.32 | 297.68 | 324.31 | 160.91 | 267.13 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.56 | 10.74 | 8.84 | 15.31 | 8.15 | 8.82 |
PS Ratio | 2.94 | 1.43 | 0.61 | 0.73 | 0.39 | 0.60 |
PB Ratio | 3.60 | 1.66 | 0.71 | 0.90 | 0.47 | 0.82 |
P/TBV Ratio | 4.19 | 1.94 | 0.88 | 1.08 | 0.57 | 1.02 |
P/FCF Ratio | 20.22 | 9.34 | 5.21 | 15.60 | 7.51 | 13.12 |
P/OCF Ratio | 15.33 | 7.09 | 4.63 | 11.70 | 5.91 | 8.74 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.83 | 1.15 | 0.47 | 0.68 | 0.35 | 0.60 |
EV/EBITDA Ratio | 13.76 | 6.28 | 3.96 | 6.78 | 3.20 | 5.77 |
EV/EBIT Ratio | 16.43 | 7.12 | 5.58 | 12.10 | 6.87 | 12.43 |
EV/FCF Ratio | 19.45 | 7.47 | 4.00 | 14.56 | 6.73 | 13.18 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.09 | 0.09 | 0.10 |
Debt / EBITDA Ratio | 0.07 | 0.09 | 0.02 | 0.69 | 0.70 | 0.68 |
Debt / FCF Ratio | - | 0.11 | 0.02 | 1.48 | 1.47 | 1.56 |
Net Debt / Equity Ratio | -0.14 | -0.13 | -0.15 | -0.09 | -0.06 | 0.00 |
Net Debt / EBITDA Ratio | -0.55 | -0.62 | -1.10 | -0.71 | -0.49 | -0.01 |
Net Debt / FCF Ratio | - | -0.73 | -1.11 | -1.52 | -1.03 | -0.01 |
Asset Turnover | - | 0.98 | 0.97 | 0.98 | 0.94 | 1.06 |
Inventory Turnover | - | 3.39 | 3.42 | 2.95 | 2.71 | 3.15 |
Quick Ratio | - | 1.32 | 1.55 | 2.45 | 2.17 | 1.24 |
Current Ratio | - | 2.44 | 2.91 | 4.53 | 3.91 | 3.00 |
Return on Equity (ROE) | - | 16.79% | 8.64% | 6.01% | 5.90% | 9.69% |
Return on Assets (ROA) | - | 9.87% | 5.12% | 3.43% | 2.99% | 3.20% |
Return on Invested Capital (ROIC) | 18.63% | 18.04% | 7.54% | 4.91% | 4.54% | 6.73% |
Return on Capital Employed (ROCE) | - | 17.90% | 9.50% | 6.10% | 5.40% | 6.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.86% | 9.31% | 11.31% | 6.53% | 12.27% | 11.33% |
FCF Yield | 4.95% | 10.70% | 19.18% | 6.41% | 13.31% | 7.62% |
Dividend Yield | 0.56% | 1.22% | - | - | - | - |
Buyback Yield / Dilution | 0.20% | - | - | - | -1.30% | -6.92% |
Total Shareholder Return | 0.76% | 1.22% | - | - | -1.30% | -6.92% |